Results of zone II flexor tendon repair in children younger than age 6 years: Botulinum toxin type A administration eased cooperation during the rehabilitation and improved outcome

Journal of Pediatric Orthopaedics

Volumn 24, Issue 6, 2004, Pages 629-633

  Tüzüner, Serdar ^a   Balci, Nilüfer ^a   Özkaynak, Sibel ^b  

^a AKDENIZ UNIVERSITY   (Turkey)

^b Department of Medical Genetics   (Turkey)

Author keywords

Botulinum; Children; Flexor tendon; Primary tendon repair

Indexed keywords

BOTULINUM TOXIN A;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; EVALUATION; FEMALE; FINGER; FLEXOR MUSCLE; FLEXOR TENDON INJURY; FOLLOW UP; GRIP STRENGTH; HUMAN; JOINT FUNCTION; MALE; MUSCLE ATROPHY; MUSCLE RELAXATION; MUSCLE TONE; MUSCLE WEAKNESS; PASSIVE MOVEMENT; PHALANX; POSTOPERATIVE COMPLICATION; POSTOPERATIVE PERIOD; PRESCHOOL CHILD; PRIORITY JOURNAL; SKIN SENSITIVITY; SURGICAL TECHNIQUE; TENDON RECONSTRUCTION; TREATMENT OUTCOME; Z PLASTY;

EID: 7044235215     PISSN: 02716798     EISSN: None     Source Type: Journal    
DOI: 10.1097/01241398-200411000-00006     Document Type: Article

References (22)

1. Amadio PC. Staged flexor tendon reconstruction in children. Ann Chir Main Memb Super. 1992;11:194-199.
2. Aoki KR. Pre-clinical update on Botox (BTX-A) purified neurotoxin complex relative to other botulinum neurotoxin preparations. Eur J Neurol. 1999;6(Suppl 4):S3-S10.
3. Belusa M, Schmickaly J. Primary flexor tendon sture in the "no man's land" of the hand. Zentralbl Chir. 1984;109:1441-1450.
4. Berndtsson L, Ejeskar A. Zone II flexor tendon repair in children. Scand J Plast Reconstr Hand Surg. 1995;29:59-64.
5. Calandruccio JH, Jobe MT, Akin K. Rehabilitation of the hand and wrist. In: Brotzman SB, ed. Clinical Orthopaedic Rehabilitation. St. Louis, MO: Mosby-Year Book, 1996:1-66.
6. Comella CL, Jankovic J, Brin MF. Use of botulinum toxin type A in the treatment of cervical dystonia. Neurology. 2000;55(12 Suppl 5):S15-S21.
7. Elliot D, Moiemen NS, Flemming AF, et al. The rupture rate of acute flexor tendon repairs mobilized by the controlled active motion regimen. J Hand Surg [Br]. 1994;19:607-612.
8. Fasching G, Schmidt B, Friedrich H, et al. Dynamic splinting after flexor tendon injuries of the hand in childhood. Handchir Mikrochir Plast Chir. 1998;30:243-248.
9. Fitoussi F, Lebellec Y, Frajman JM, et al. Flexor tendon injuries in children: factors influencing prognosis. J Pediatr Orthop. 1999;19:818-821.
10. Graham HK, Aoki KR, Autti-Ramo I, et al. Recommendations for the use of botulinum toxin type A in the management of cerebral palsy. Gait Posture. 2000;11:67-79.
11. Grobbelaar AO, Hudson DA. Flexor tendon injuries in children. J Hand Surg [Br]. 1994;19:696-698.
12. Hester TR Jr, Hill L, Nahai F. Early mobilization of repaired flexor tendons within digital sheath using an internal profundus splint: experimental and clinical data. Ann Plast Surg. 1984;12:187-198.
13. Karp BI. The role of botulinum toxin type A in the management of occupational dystonia and writer's cramp. In: Brin MF, Hallett M, Jankovic J, eds. Scientific and Therapeutic Aspects of Botulinum Toxin. Philadelphia: Lippincott Williams & Wilkins, 2002:251-258.
14. Kato H, Minami A, Suenaga N, et al. Long-term results after primary repairs of zone 2 flexor tendon lacerations in children younger than age 6 years. J Pediatr Orthop. 2002;22:732-735.
15. Kayali C, Eren A, Agus H, et al. The results of primary repair and early passive rehabilitation in zone II flexor tendon injuries in children. Acta Orthop Traumatol Turc. 2003;37:249-253.
16. Koman LA, Mooney JF 3rd, Smith BP. et al. Management of spasticity cerebral palsy with botulinum-A toxin: report of a preliminary, randomized, double-blind trial. J Pediatr Orthop. 1994;14:299-303.
17. O'Connell SJ, Moore MM, Strickland JW, et al. Results of zone I and zone II flexor tendon repairs in children. J Hand Surg [Am]. 1994;19:48-52.
18. Peck FH, Bucher CA, Watson JS, et al. A comparative study of two methods of controlled mobilization of flexor tendon repairs in zone 2. J Hand Surg [Br]. 1998;23:41-45.
19. Schiavo G, Benfenati F, Poulain B, et al. Tetanus and botulinum-B neurotoxins block neurotransmitter release by proteolytic cleavage of synaptobrevin. Nature. 1992;359:832-835.
20. Strickland JW, Glogovac SV. Digital function following flexor tendon repair in zone II: a comparison of immobilization and controlled passive motion techniques. J Hand Surg [Am]. 1980;5:537-543.
21. Tuncay I, Ege A, Akpinar F, et al. Flexor tendon injuries of children in zone 2 (FDS repair or not). Chir Organi Mov. 2002;87:241-248.
22. Vahvanen V, Gripenberg L, Nuutinen P. Flexor tendon injury of the hand in children. Scand J Plast Reconstr Surg. 1981;15:43-48.